Abstract
Falling is one of the most disabling features of Parkinson’s disease (PD). Many cross-sectional studies, case–control studies, and prospective studies have attempted to identify risk factors or predictors of falls, but consistent results are yet to be obtained because of the various factors involved. We prospectively studied patients with various severities of PD to identify risk factors for future falls during 2.5 years of follow-up. We registered 95 patients with PD, and 83 patients were included in data analysis. A total of 23 variables were evaluated by multivariate logistic regression analysis. Thirty-one patients (37 %) had a previous history of falling, and 26 patients (30 %) experienced their first fall. The prevalence of falls at 2.5 years was 62 % (52 of 83 patients). Frontal Assessment Battery (FAB) score (OR 1.393, p = 0.005, 95 % CI 1.104–1.759) and history of fall present (OR 0.142, p = 0.002, 95 % CI 0.042–0.48) were related to falling on multiple logistic regression analysis. The following variables differed significantly between patients with first falls and those without falling: levodopa equivalent dose (p = 0.023), UPDRS part I (p = 0.006), SF-8 (p = 0.017), and FAB (p = 0.026). Calculation of the FAB score may be useful for predicting the risk of future falls in patients with various severities of PD. Our results suggest that a low FAB score combined with a history of falling within the past 6 months carries an increased risk of future falls.
Similar content being viewed by others
References
Pickering RM, Grimbergen YA, Rigney U et al (2007) A meta-analysis of six prospective studies of falling in Parkinson’s disease. Mov Disord 22:1892–1900
Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23:837–844
Melton LJ 3rd, Leibson CL, Achenbach SJ et al (2006) Fracture risk after the diagnosis of Parkinson’s disease: influence of concomitant dementia. Mov Disord 21:1361–1367
Dorsey ER, Constantinescu R, Thompson JP et al (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68:384–386
Kataoka H, Tanaka N, Saeki K et al (2011) Risk of falling in Parkinson’s disease at the Hoehn–Yahr stage III. Eur Neurol 66:298–304
Lee AC, Harris JP (1999) Problems with perception of space in Parkinson’s disease. Neuro-Ophthalmology 22:1–15
Bloem BR, Hausdorff JM, Visser JE, Giladi N (2004) Falls and freezing of gait in Parkinson’s disease: a review of two interconnected, episodic phenomena. Mov Disord 19:871–884
Kataoka H, Tanaka N, Saeki K, Kiriyama T, Ueno S (2014) Low frontal assessment battery score as a risk factor for falling in patients with Hoehn–Yahr Stage III Parkinson’s disease: a 2-year prospective study. Eur Neurol 71:187–192
Nutt JG, Marsden CD, Thompson PD (1993) Human walking and higher-level gait disorders, particularly in the elderly. Neurology 43:268–279
Atchison PR, Thompson PD, Frackowiak RS, Marsden CD (1993) The syndrome of gait ignition failure: a report of six cases. Mov Disord 8:285–292
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184
Gilman S, Low PA, Quinn N et al (1999) Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163:94–98
Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9
Fahn S, Elton R (1987) Members of UPDRS Development Committee. Unified Parkinson’s disease Rating Scale. In: Fahn S, Marsden CD, Caine DB, Goldstein M (eds) Recent development in Parkinson’s disease, 2nd edn. Macmillan Health Care Information, Florham Park, pp 153–163 (293–304)
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442
Tinetti ME, Speechley M, Ginter SF (1988) Risk factors for falls among elderly persons living in the community. N Engl J Med 319:1701–1707
Minguez-Castellanos A, Escamilla-Sevilla F, Katati MJ et al (2005) Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson’s disease: target related effect or selection bias? J Neurol Neurosurg Psychiatry 76:34–39
Schindehütte J, Trenkwalder C (2007) “Atypical anti-psychotics” are substances of choice in treating drug-induced psychosis (DP) in Parkinson’s disease (PD). Clin Neurol Neurosurg 109:188–191
Gehlsen GM, Whaley MH (1990) Falls in the elderly: part II, Balance, strength, and flexibility. Arch Phys Med Rehabil 71:739–741
Balash Y, Peretz C, Leibovich G, Herman T, Hausdorff JM, Giladi N (2005) Falls in outpatients with Parkinson’s disease: frequency, impact and identifying factors. J Neurol 252:1310–1315
Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH (2001) Prospective assessment of falls in Parkinson’s disease. J Neurol 248:950–958
Latt MD, Lord SR, Morris JG, Fung VS (2009) Clinical and physiological assessments for elucidating falls risk in Parkinson’s disease. Mov Disord 24:1280–1289
Paul SS, Sherrington C, Canning CG, Fung VS, Close JC, Lord SR (2014) The relative contribution of physical and cognitive fall risk factors in people with Parkinson’s disease: a large prospective cohort study. Neurorehabil Neural Repair 28:282–290
Voss TS, Elm JJ, Wielinski CL et al (2012) Fall frequency and risk assessment in early Parkinson’s disease. Parkinsonism Relat Disord 18:837–841
Amboni M, Barone P, Hausdorff JM (2013) Cognitive contributions to gait and falls: evidence and implications. Mov Disord 28:1520–1533
Muir SW, Gopaul K, Montero Odasso MM (2012) The role of cognitive impairment in fall risk among older adults: a systematic review and meta-analysis. Age Ageing 41:299–308
Rochester L, Nieuwboer A, Baker K et al (2008) Walking speed during single and dual tasks in Parkinson’s disease: which characteristics are important? Mov Disord 23:2312–2318
Mak MK, Wong A, Pang MY (2014) Impaired executive function can predict recurrent falls in Parkinson’s disease. Arch Phys Med Rehabil 95:2390–2395
Fling BW, Cohen RG, Mancini M et al (2014) Functional reorganization of the locomotor network in Parkinson patients with freezing of gait. PLoS ONE 9:e100291
Shine JM, Matar E, Ward PB et al (2013) Freezing of gait in Parkinson’s disease is associated with functional decoupling between the cognitive control network and the basal ganglia. Brain 136:3671–3681
Amboni M, Cozzolino A, Longo K, Picillo M, Barone P (2008) Freezing of gait and executive functions in patients with Parkinson’s disease. Mov Disord 23:395–400
Bugalho P, Vale J (2011) Brief cognitive assessment in the early stages of Parkinson disease. Cogn Behav Neurol 24:169–173
Wood BH, Bilclough JA, Bowron A, Walker RW (2002) Incidence and prediction of falls in Parkinson’s disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry 72:721–725
Mak MK, Pang MY (2009) Fear of falling is independently associated with recurrent falls in patients with Parkinson’s disease: a 1-year prospective study. J Neurol 256:1689–1695
Hiorth YH, Larsen JP, Lode K, Pedersen KF (2014) Natural history of falls in a population-based cohort of patients with Parkinson’s disease: an 8-year prospective study. Parkinsonism Relat Disord 20:1059–1064
Dubois B, Pillon B, Sternic N, Lhermitte F, Agid Y (1990) Age-induced cognitive disturbances in Parkinson’s disease. Neurology 40:38–41
Lindholm B, Hagell P, Hansson O, Nilsson MH (2014) Factors associated with fear of falling in people with Parkinson’s disease. BMC Neurol 14:19
Brown RG, Dittner A, Findley L, Wessely SC (2005) The Parkinson fatigue scale. Parkinsonism Relat Disord 11:49–55
Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD (2000) Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 6:165–170
Conflicts of interest
The authors report no conflict of interest related to our paper.
Ethical standard
This study has been approved by the appropriate ethics committee and has therefore been performed in the accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kataoka, H., Ueno, S. Low FAB score as a predictor of future falling in patients with Parkinson’s disease: a 2.5-year prospective study. J Neurol 262, 2049–2055 (2015). https://doi.org/10.1007/s00415-015-7814-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-015-7814-4